Author

F. Boue

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 1 Organism:rat· 1

Frequent Co-Authors

E. Monchatre-Leroy· 3 shared E. Picard-Meyer· 3 shared A. Servat· 2 shared C. Richomme· 2 shared F. J. Salguero· 2 shared M. Wasniewski· 2 shared S. Lesellier· 2 shared A. Coggon· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

E. Monchatre-Leroy

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic

M. Wasniewski, F. Boue, C. Richomme, E. Simon-Loriere, S. Van der Werf, F. Donati, V. Enouf, Y. Blanchard, V. Beven, E. Leperchois, B. Leterrier, S. Corbet, M. Le Gouil, E. Monchatre-Leroy, E. Picard-Meyer

This study investigates SARS-CoV-2 and other viruses in French mink farms, finding high seropositivity and genetic diversity in one farm and co-circulation of other coronaviruses in others.

bioRxiv · Feb 2, 2023 · PreprintMicrobiology

Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model

P. Bessiere, M. Wasniewsk, E. Picard-Meyer, A. Servat, T. Figueroa, C. Foret-Lucas, A. Coggon, S. Lesellier, F. Boue, N. Cebron, B. Gausseres, C. Trumel, G. Foucras, F. J. Salguero, E. Monchatre-Leroy, R. Volmer

This study shows that intranasal type I interferon treatment is effective only when given before clinical signs onset in a SARS-CoV-2 hamster model, not after symptoms appear.

bioRxiv · Feb 9, 2021Microbiology

Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2

E. Monchatre-Leroy, S. Lesellier, M. Wasniewski, E. Picard-Meyer, C. Richomme, F. Boue, S. Lacote, S. Murri, C. Pulido, J. Vulin, F. J. Salguero, M. A. Legouilh, A. Servat, P. Marianneau

This study infects hamsters and ferrets with low-dose SARS-CoV-2 to compare disease severity, viral spread, and immune responses between species.

bioRxiv · Sep 24, 2020Microbiology